课题基金 / 基金详情

SMEK1在减数分裂中的作用及其导致生精过程障碍的机制研究

批准号:
32070586
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
刘奇迹
依托单位:
学科分类:
表型、行为与疾病的遗传学基础
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
刘奇迹

项目摘要

结项摘要

刘奇迹的其他基金

相似基金

相关文献

中文摘要
精子发生过程中的减数分裂异常是导致男性不育的重要原因之一,蛋白磷酸化基因在其中发挥着重要作用。课题组前期鉴定了蛋白磷酸酶2A家族的基因SMEK1(又名蛋白磷酸酶4调节亚基3A,PPP4R3A)是一个新的罕见病致病基因。功能研究发现Smek1基因敲除雄性小鼠不育,睾丸脏器系数显著减小,并有曲细精管生精细胞严重缺如,异常小管减数分裂前中期细胞比例明显增多。据此我们提出假说:SMEK1基因在减数分裂及精子发生过程中起着重要的作用,该基因缺失导致精母细胞前中期过渡时期障碍或中期阻滞,从而导致精子发生障碍。为此,课题组拟通过对条件敲除小鼠生育力测试、对粗线期检查点、DNA损伤感知检查点及负责中后期转换的纺锤体检查点(SAC)等进行分析,利用蛋白质谱分析及ChIP-seq寻找相互作用分子;同时在男性无精子症患者中对SMEK1基因进行突变分析,以明确SMEK1在减数分裂及精子发生中的作用提供依据。
英文摘要
Spermatogenesis is a complex developmental process by which male germline stem cells divide and differentiate to produce mature spermatozoa. In mammalian testes, this process occurs within seminiferous tubules and consists of three phases: mitosis, meiosis, and spermiogenesis . In the second phase of spermatogenesis, meiosis is characterized by chromosome recognition, pairing, synapsis, recombination, and segregation of homologous chromosomes. Any mistake in meiotic recombination can lead to meiotic arrest or chromosome segregation failure, resulting in severe consequences including infertility..Protein phosphorylation and dephosphorylation are very critical for spermatogenesis . The phosphorylation status are regulated by a conserved cohort of protein kinases and phosphatases. However, protein phosphatases have been much less studied than protein kinases. In previous sdudies, we identified that PPP4R3A(SMEK1) is a new rare disease gene by genetic studies. Further studies revealed that male SMEK1 knock out mice are infertile. SMEK1 encodes suppressor of MEK null 1(SMEK1), also known as PPP4R3A (Protein Phosphatase 4 Regulatory Subunit 3A), which was initially described as a suppressor of MAPK cascade with unknown mechanism and a regulatory subunit of PP4 enzyme.Compared with controls, the testes of KO mice were much smaller and the testis weight to body weight ratio of KO was significantly reduced. Results of histology of the epididymides and testes by H&E staining showed that almost no mature spermatozoa were found in the epididymal lumens of KO mice. Most of the spermatocytes arrested at the pachytene stage. Based on above results,we hypothesized that SMEK1 plays a critical role in spermatogenesis via affecting pachytene stage checkpoint, DSD repair checkpoint or spindle assemble checkpoint. .In this proposed project, we aim to confirm the hypothesis by 1) in vitro studies to determine the type and period of germ cell loss to provide more functional supportive evidences, 2)confirm that Smek1 is involved in the regulation of the prophase metaphase transition or metaphase arrest checkpoint in mice, 3)Using iTRAQ/TMT and ChIP-seq to find the interaction protein, 4)screening male infertile cases to find the mutations in the SMEK1 gene. Our study will provide a better understanding of biological function of SMEK1 and the male infertility.
课题组前期发现Smek1敲除小鼠表现为雄性不育及睾丸减小的表型,敲除小鼠支持细胞、精原干细胞以及分化和未分化精原细胞的数量等皆表型正常,从而排除了生殖细胞早期的自我更新和分化问题带来的生精异常。随后,我们利用小鼠睾丸精母细胞核染色体铺片的免疫荧光实验来检测敲除小鼠减数分裂的一系列分子生物学事件是否异常,以此来探究减数分裂是否受损。发现当生殖细胞中缺失SMEK1后,粗线期的精母细胞出现凋亡,这导致双线期细胞比例相对升高,在铺片和组织切片中表现为双线期样的核分裂象增多、生精时相紊乱以及曲细精管中精母细胞排布异常。我们观察到即便这些缺失SMEK1的精母细胞可以进入减数第一次分裂的中期,但是纺锤体组装的异常导致它们仍旧无法完成正常的分裂,表现为多极或轴偏转纺锤体增多,中期分裂相的精母细胞DNA降解的比例增多,纺锤体装配检查点激活阻止了细胞周期进程。随后,为了探究SMEK1发挥作用的机制,我们利用双荧光素酶报告基因技术和染色质免疫共沉淀(ChIP)技术等实验方法,验证了SMEK1对重组酶Rad51和纺锤体装配检查点的关键组分BUBR1的去泛素化酶Usp10的转录抑制作用,发现当Smek1敲除后,前期的精母细胞发生Rad51的累积和清除障碍导致同源重组缺陷进而细胞发生凋亡;那些幸存的细胞中的Usp10由于缺少SMEK1的转录抑制作用从而发生累积进而使BUBR1降解减少导致纺锤体检查点的激活,细胞周期的再次受阻最终导致细胞凋亡。综上所述,该课题利用小鼠表型和体外机制探究共同验证了SMEK1对Rad51和Usp10的负调控对雄鼠的生精过程至关重要。本项目共培养博士研究生2名,硕士研究生4名。在Disease models & mechanisms, Advanced Sciences等杂志发表SCI论文7篇。
一新的耳聋基因RGS12通过影响毛细胞参与耳聋发生的作用机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    刘奇迹
  • 依托单位:
一家族性单基因遗传自身免疫病致病基因SOX13的发现及功能分析
  • 批准号:
    81873878
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘奇迹
  • 依托单位:
一新的遗传性痉挛性截瘫致病基因SMEK1在疾病发生中的作用及分子病理机制研究
  • 批准号:
    81671114
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2016
  • 负责人:
    刘奇迹
  • 依托单位:
系统性红斑狼疮新易感基因WDFY4在B细胞发育中的作用及其致病机制研究
  • 批准号:
    81471602
  • 项目类别:
    面上项目
  • 资助金额:
    90.0万元
  • 批准年份:
    2014
  • 负责人:
    刘奇迹
  • 依托单位:
国内基金
海外基金